{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:59:07Z","timestamp":1789469947196,"version":"build-2803163510"},"reference-count":10,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"unspecified","delay-in-days":29,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2025,1,6]]},"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Short-term improvements in quality of life (QOL) have been reported in adult congenital heart disease patients with systemic right ventricle (sRV) failure after treatment with sacubitril\/valsartan. This study aimed to evaluate the medium-term QOL changes in sRV failure patients treated with sacubitril\/valsartan.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In this single-centre, prospective cohort study, patients with symptomatic sRV failure completed the Netherlands Organisation for Applied Scientific Research\/Academic Hospital Leiden Questionnaire for Adult\u2019s Health-Related Quality of Life (TAAQOL) at baseline and after starting treatment with sacubitril\/valsartan. The TAAQOL was taken at structured outpatient follow-up moments after 6, 12, 24 and 36 months of treatment. Linear mixed effects models were used to evaluate the medium-term changes in 12 QOL domains.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 40 sRV failure patients initiated on sacubitril\/valsartan, 35 completed the titration phase, and 31 filled in a total of 98 TAAQOL questionnaires (response rate 77.5%). Significant improvements in gross motoric functioning (p=0.008), cognitive function (p=0.002), sleep (p=0.041), social functioning (p&lt;0.001) and daily activities (p=0.001) were observed during follow-up. No significant changes were observed in fine motoric functioning, pain, sexuality, vitality, positive, depressive or aggressive emotions. Of interest, periods with restrictions relating to the COVID-19 pandemic did not significantly influence changes over time in any of the 12 QOL domains.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Sacubitril\/valsartan treatment was associated with persistent medium-term QOL improvements in gross motoric functioning, cognitive function, sleep, social functioning and daily activities domains in sRV failure patients. Self-perceived QOL of sRV failure patients may be amenable to improvement with sacubitril\/valsartan.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/openhrt-2024-003009","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T10:00:16Z","timestamp":1738231216000},"page":"e003009","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Sacubitril\/valsartan is associated with improvements in quality of life in adult congenital heart disease patients with systemic right ventricular failure"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3845-1678","authenticated-orcid":false,"given":"Ralph M.L.","family":"Neijenhuis","sequence":"first","affiliation":[{"name":"Center for Congenital Heart Disease Amsterdam Leiden (CAHAL), Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands"},{"name":"Department of Cardiology, Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4893-6575","authenticated-orcid":false,"given":"Marieke","family":"Nederend","sequence":"additional","affiliation":[{"name":"Center for Congenital Heart Disease Amsterdam Leiden (CAHAL), Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands"},{"name":"Department of Cardiology, Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna E.","family":"van Groningen","sequence":"additional","affiliation":[{"name":"Center for Congenital Heart Disease Amsterdam Leiden (CAHAL), Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands"},{"name":"Department of Cardiology, Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9132-0418","authenticated-orcid":false,"given":"Monique R.M.","family":"Jongbloed","sequence":"additional","affiliation":[{"name":"Center for Congenital Heart Disease Amsterdam Leiden (CAHAL), Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands"},{"name":"Department of Cardiology, Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands"},{"name":"Department of Anatomy & Embryology, Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert W.","family":"Vliegen","sequence":"additional","affiliation":[{"name":"Center for Congenital Heart Disease Amsterdam Leiden (CAHAL), Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands"},{"name":"Department of Cardiology, Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Wouter","family":"Jukema","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands"},{"name":"Netherlands Heart Institute, Utrecht, Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippine","family":"Ki\u00e8s","sequence":"additional","affiliation":[{"name":"Center for Congenital Heart Disease Amsterdam Leiden (CAHAL), Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands"},{"name":"Department of Cardiology, Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9312-2338","authenticated-orcid":false,"given":"Anastasia D.","family":"Egorova","sequence":"additional","affiliation":[{"name":"Center for Congenital Heart Disease Amsterdam Leiden (CAHAL), Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands"},{"name":"Department of Cardiology, Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"key":"2025081710310306000_12.1.e003009.1","doi-asserted-by":"publisher","DOI":"10.1017\/S1047951112002351"},{"key":"2025081710310306000_12.1.e003009.2","doi-asserted-by":"publisher","DOI":"10.1023\/B:QURE.0000021690.84029.a3"},{"key":"2025081710310306000_12.1.e003009.3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.031544"},{"key":"2025081710310306000_12.1.e003009.4","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2020-318074"},{"key":"2025081710310306000_12.1.e003009.5","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2022-322332"},{"key":"2025081710310306000_12.1.e003009.6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/ehjdh\/ztab028","article-title":"Potential of eHealth smart technology in optimization and monitoring of heart failure treatment in adults with systemic right ventricular failure","volume":"2","author":"Nederend","year":"2021","journal-title":"Eur Heart J Digit Health"},{"key":"2025081710310306000_12.1.e003009.7","doi-asserted-by":"publisher","DOI":"10.1136\/heart.87.4.356"},{"key":"2025081710310306000_12.1.e003009.8","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.009848","article-title":"Safety and Efficacy of Sacubitril\/Valsartan in Patients With a Failing Systemic Right Ventricle: A Prospective Single-Center Study","volume":"16","author":"Fusco","year":"2023","journal-title":"Circ Heart Fail"},{"key":"2025081710310306000_12.1.e003009.9","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003430","article-title":"Health-Related Quality of Life Outcomes in PARADIGM-HF","volume":"10","author":"Lewis","year":"2017","journal-title":"Circ Heart Fail"},{"key":"2025081710310306000_12.1.e003009.10","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/eurheartj\/ehad890","article-title":"Angiotensin receptor-neprilysin inhibitor vs. placebo in congenital systemic right ventricular heart failure: the PARACYS-RV trial","volume":"45","author":"Chaix","year":"2024","journal-title":"Eur Heart J"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2024-003009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T17:31:08Z","timestamp":1755451868000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2024-003009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,30]]},"published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1136\/openhrt-2024-003009"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2024-003009","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}